FOR IMMEDIATE RELEASE
Singderm Filler Achieves 92.7% Efficacy at 12 Months in Global Clinical Trial, Validated by Landmark Thailand Masterclass
Bangkok, Thailand – Singderm, a globally certified dermal filler brand, has demonstrated unprecedented clinical performance in its Thailand Masterclass led by renowned physician Dr. Worawat Nolah. Three top KOLs (Hack Anantaya, Chalidaorn PinNy, Thantaya Thuranuch) received multi-zone injections with zero complications, reinforcing Singderm’s 92.7% 12-month efficacy rate from a 100-subject clinical trial.

Clinical Excellence Backed by Data
According to Singderm’s official brochure:
92.7% efficacy at 12 months measured by Wrinkle Severity Rating Scale (WSRS)
Median pain score of 2.0 (0-10 scale) in independent assessments
100% nodule-free results across 3 injection sites (China, Italy, Brazil)
Dr. Worawat Nolah emphasized:
"Singderm’s 24mg/mL HA concentration and SingLink™ cross-linking technology deliver unmatched stability – crucial for natural outcomes in dynamic areas like lips and nasolabial folds."
KOLs Verify Real-World Performance
ChalidaornPinNy on longevity:
"No lumps or migration after 6 months – exactly as the brochure promises!"HackAnantaya on comfort:
"The BD Hylok™ syringe made injections seamless – I felt only mild pressure."ThantayaThuranuch on versatility:
"From under-eyes to temples, Singderm held shape identically."
Why Singderm Stands Apart
Patented Technology
SingLink™ Cross-Linking : Ensures 12-month durability
StabilityTech™ Formula : Prevents migration in mobile zones
Safety Assurance
Non-Animal HA (Streptococcus fermentation, JP/EP certified)
Terminal Sterilization at 121°C
Enhanced Experience
BD Hylok™ Prefilled Syringe with integrated Luer Lock
0.3% Lidocaine for minimized pain
Global Compliance & Availability
Certified under CE 2292, NMPA, and ISO 13485, Singderm is available worldwide via distributors like SingdermThailand. As stated by Dr. Lucia Linde
"Perfect for plumping lips and full-face rejuvenation – I love this product!"
-
singclean | 2025-08-19
Singclean Medical to Debut Singderm® at IMCAS China 2026 – A PreviewShanghai, August 2026 – The 5th IMCAS China Congress is set to open on August 27–29, 2026 at the W Shanghai – The Bund. As one of the most anticipated gatherings in medical aesthetics, the event will bring together global experts, innovators, and clinicians. Among the featured exhibitors, Hangzhou Singclean Medical Products Co., Ltd. will make a strong impression by unveiling its premium hyaluronic acid filler Singderm® to the international community. -
singclean | 2025-08-19
Singclean to Showcase Comprehensive Healthcare Solutions at IMCAS China 2026, MEDITECH 2026 and MEDICAL FAIR ASIA 2026As part of its continued global expansion, Singclean Medical will participate in three major international healthcare exhibitions across Asia and Latin America in the second half of 2026: IMCAS China 2026 in Shanghai, MEDITECH 2026 in Bogotá, and MEDICAL FAIR ASIA 2026 in Singapore. These events provide valuable opportunities to connect with healthcare professionals, distributors, and industry partners while presenting Singclean's latest innovations in biomaterials and medical technology. -
singclean | 2025-08-19
Singclean Medical to Showcase Innovative Healthcare Solutions at WHX Bangkok 2026 and Meditech Colombia 2026Hangzhou, China | July 2026 Singclean Medical will participate in two leading international healthcare exhibitions this July—WHX Bangkok 2026 in Thailand and Meditech Colombia 2026 in Colombia—continuing its commitment to expanding its global presence and strengthening partnerships across Southeast Asia and Latin America.